학술논문

Testosterone is Associated With Nonalcoholic Steatohepatitis and Fibrosis in Premenopausal Women With NAFLD
Document Type
article
Source
Clinical Gastroenterology and Hepatology. 19(6)
Subject
Biomedical and Clinical Sciences
Clinical Sciences
Clinical Research
Chronic Liver Disease and Cirrhosis
Women's Health
Contraception/Reproduction
Hepatitis
Liver Disease
Digestive Diseases
Prevention
Aging
Nutrition
Obesity
Oral and gastrointestinal
Good Health and Well Being
Adult
Female
Fibrosis
Humans
Liver
Liver Cirrhosis
Non-alcoholic Fatty Liver Disease
Obesity
Abdominal
Testosterone
Androgens
Hepatic Inflammation
Sex Hormones
Nonalcoholic Fatty Liver Disease
Abdominal Adiposity
NASH Clinical Research Network
Gastroenterology & Hepatology
Clinical sciences
Language
Abstract
Background & aimsHigher testosterone contributes to imaging-confirmed nonalcoholic fatty liver disease (NAFLD) in women, but whether testosterone influences their disease severity is unknown.MethodsThe association of free testosterone (free T) with nonalcoholic steatohepatitis (NASH) was determined in pre-menopausal women with biopsy-confirmed NAFLD (n = 207). Interaction testing was performed for age and free T given decline in testosterone with age, and association of aging with NASH. Regression models adjusted for abdominal adiposity, diabetes, and dyslipidemia.ResultsMedian age was 35 yrs (interquartile range, 29-41); 73% were white, 25% Hispanic; 32% had diabetes, 93% abdominal adiposity, and 95% dyslipidemia. 69% had NASH, 67% any fibrosis, and 15% advanced fibrosis. Higher free T levels were associated with NAFLD severity in younger women (interaction P value